FXR: structures, biology, and drug development for NASH and fibrosis diseases
Crossref DOI link: https://doi.org/10.1038/s41401-021-00849-4
Published Online: 2022-02-25
Published Print: 2022-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tian, Si-yu
Chen, Shu-ming
Pan, Cheng-xi
Li, Yong
Text and Data Mining valid from 2022-02-25
Version of Record valid from 2022-02-25
Article History
Received: 5 October 2021
Accepted: 21 December 2021
First Online: 25 February 2022
Competing interests
: The authors declare no competing interest.